期刊文献+

导向性IFN-α2a-α-MSH基因的克隆、表达、纯化及鉴定 被引量:1

Cloning,expression,purification and identification of IFN-α2a-α-MSH fusion gene
下载PDF
导出
摘要 目的:构建导向性IFN-α2a-α-MSH融合基因的原核表达载体,并建立重组蛋白的原核高效表达体系.方法:将本实验室已构建的pET-22b(+)IFN-α2a-NGR用BamH I和SalI限制性内切酶进行双酶切,将得到的大片段与设计的α-MSH多肽片段退火后的产物进行连接,构建原核表达载体pET-22b(+)IFN-α2a-α-MSH,将序列鉴定正确的重组质粒转化入Rosetta-gamiTM2(DE3)大肠杆菌,IPTG诱导表达目的蛋白.对表达产物进行SDS-PAGE及Western Blot鉴定.结果:在大肠杆菌中成功实现了IFN-α2a-α-MSH的稳定高效表达,表达产物以包涵体形式存在,采用超声裂菌的方法,用疏水作用层析技术获得较高纯度的重组蛋白.结论:成功克隆、表达和纯化了IFN-α2a-α-MSH蛋白. AIM : To construct interferons-α2a ( IFN-α2a)-α melanocyte-stimulating hormone (MSH) fusion gene and a higt prokaryotic expression system of IFN-α2a-α-MSH. METHODS: Plasmid pET-22b ( + ) IFN-α2a-NGR in our laboratory, was digested with the BamH I and Sal I restriction enzymes, and then connected to the annealed α-MSH peptide sequences to construc prokaryotic expression vector pET-22b( + ) IFN-α2a-α-MSH . The correct sequence that had been identified was transfected int( Rosetta-gamiTM2( DE3 ) cell. IPTG induced fusion protein IFN-α2a-α-MSH expression. The expression of IFN-α2a-α-MSH was detected by SDS-PAGE and Western Blot. RESULTS: The IFN-α2a-α-MSH fusion protein in form of inclusion body,was successfully and stably expressed in E. coli. After the E. coli was lysed by ultrasonic wave, Phenyl Sepharose 6 Fast Flow ( high sub) was used to get the purified recombinant protein. CONCLUSION: The fusion protein of IFN-α2a-α-MSH has been successfully expressed and purified.
出处 《第四军医大学学报》 北大核心 2007年第12期1084-1087,共4页 Journal of the Fourth Military Medical University
关键词 干扰素 Α-2A α促黑素 大肠杆菌 基因表达 pET-22b(+)载体 interferon Alfa-2a Alpha Escherichia coli geneexpression pET-22b( + ) vector
  • 相关文献

参考文献7

  • 1Zhu N,Lalla R,Eves P,et al.Melanoma cell migration is up regulated by tumour necrosis factor-alpha and suppressed by alpha-melanocyte-stimulating hormone[ J ].Br J Cancer,2004,90 (7):1457-1463.
  • 2Eves P,Haycock J,Layton C,et al.Anti-inflammatory and anti-invasive effects of alpha-melanocyte-stimulating hormone in human melanoma cell[ J].Br J Cancer,2003,89(10):2004 -2014.
  • 3Froidevanx S,Calame-Christe M,Tanner H,et al.A novel DOTAalpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis[ J ].J Nucl Med,2002,43 (12):1699-1706.
  • 4刘磊,孟洁如,赵宁,颜真,张英起.融合蛋白IFN-α2b-NGR在荷瘤小鼠体内的肿瘤局部分布及组织定位[J].第四军医大学学报,2004,25(15):1400-1402. 被引量:1
  • 5Jieru M,Nan M,Zhen Y,et al.NGR enhanced the anti-angiogenic activity of tum-5[J].J Biochem,2006,140(2):1 -6.
  • 6Murata J,Ayukawa K,Ogasawara M,et al.Alpha-melanocyte stimulating hormone blocks invasion of reconstituted basement membrane(Matrigel) by murine B16 melanoma cells[ J ].Invasion Metastasis,1997,17:82-93.
  • 7李蠡,邢新,薛春雨,张敬德.α-黑素细胞刺激素对恶性黑色素瘤细胞Fas/FasL表达的影响及其与凋亡的关系[J].临床肿瘤学杂志,2005,10(3):230-234. 被引量:2

二级参考文献19

  • 1Kirkwood J. Cancer immunotherapy: The interferon-alpha experience[J]. Semin Oncol,2002;29:18-26.
  • 2Brassard DL, Grace MJ, Bordens RW. Interferon-alpha as an immunotherapeutic protein[J]. J Leukoc Biol, 2002;71(4):565-581.
  • 3Jonasch E, Haluska FG. Interferon in oncological practice: Review of interferon biology, clinical applications, and toxicities[J]. Oncologist, 2001;6(1):34-55.
  • 4Linda A, Landonl, Susan L. Combinatorial discovery of tumortargeting peptides using phage display[J]. J Cell Biochem, 2003; 90:509-517.
  • 5Nilsson F, Tarli L, Viti F, et al. The use of phage display for the development of tumourtargeting agents[J]. Adv Drug Deliv Rev, 2000;43:165-196.
  • 6Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model[J]. Science, 1998; 279:377-380.
  • 7Pasqualini R, Koivunen E, Kain R, et al. Aminopeptidase N is a receptor for tumor-homingpeptides and a target for inhibiting angiogenesis[J]. Cancer Res, 2000; 60:722-727.
  • 8Curnis F, Arrigoni G, Sacchi A, et al. Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells[J]. Cancer Res, 2002;62:867-874.
  • 9Colombo G, Curnis F, De Mori GM, et al. Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif[J]. J Biol Chem, 2002;277(49):47891-47897.
  • 10Pastorino F, Brignole C, Marimpietri D, et al. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy[J]. Cancer Res, 2003;63(21):7400-7409.

共引文献1

同被引文献13

  • 1李蠡,邢新,薛春雨,张敬德.α-黑素细胞刺激素诱导黑色素瘤细胞凋亡的作用[J].中国临床康复,2005,9(6):117-119. 被引量:1
  • 2李蠡,邢新,薛春雨,张敬德.α-黑素细胞刺激素对恶性黑色素瘤细胞Fas/FasL表达的影响及其与凋亡的关系[J].临床肿瘤学杂志,2005,10(3):230-234. 被引量:2
  • 3吴振林,董坚.多肽分子在肿瘤基础和临床中的应用[J].昆明医学院学报,2006,27(5):115-119. 被引量:1
  • 4Brassard DL, Grance M J, Bordens RW. Interferon-alpha as an immunotherapeutic protein [J]. J Leukoc Biol, 2002, 71 (4):565-581.
  • 5Harem C, Verma S, Petrella T, et al. Biochemotherapy for the treatment of metastatic malignant melanoma: a systematic review[J].Cancer Treat Rev, 2008, 34 (2): 145-156.
  • 6Dadachova E, Casadevall A. Renaissance of targeting molecules for melanoma [J]. Cancer Biother Radio Pharm, 2006, 21 (6): 545- 552.
  • 7Zhu N, Lalla R, Eves P, et al. Melanoma cell migration is upregulated by tumour necrosis factor-alpha and suppressed by alphamelanocyte-stimulating hormone [J]. Br J Cancer, 2004, 90 (7): 1457-1463.
  • 8Eves P, Haycock J, Layton C, et al. Anti-inflammatory and anti-invasive effects of alpha-melanocyte-stimulating hormone in human melanoma cell [J].Br J Cancer, 2003, 89 (10): 2004-2015.
  • 9Froidevaux S, Calame-Christe M, Tanner H, et al. A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis [J ]. J Nucl Med, 2002, 43 (12): 1699-1706.
  • 10McQuade P, Miao Y, Yoo J, et al. Imaging of melanoma using 64Cu-and 86Y-DOTA-ReCCMSH (Argll), a cyclized peptide analogue of alpha-MSH [J]. J Med Chem, 2005, 48 (8): 2985- 2992.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部